Paper10993
Purification and characterization of bile salt hydrolase from Bacteroides fragilis subsp. fragilis.
Stellwag EJ and 1 other. Biochim Biophys Acta, 1976. Cited by 119 papers, by iCite.
Cite this record
ConductScience Library. Purification and characterization of bile salt hydrolase from Bacteroides fragilis subsp. fragilis. Papers, record 10993. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10993
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Purification and characterization of bile salt hydrolase from Bacteroides fragilis subsp. fragilis.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amidohydrolases | Major topic |
| Bacteroides fragilis | Major topic |
| Bile Acids and Salts | |
| Glycocholic Acid | |
| Hydrogen-Ion Concentration | |
| Kinetics | |
| Molecular Weight | |
| Spheroplasts | |
| Structure-Activity Relationship |
Source PubMed
Cited by60
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42371546 | The multifaceted role of bile acids in breast cancer: pathogenesis, therapeutic potential, and drug delivery. | PeerJ | 2026 | https://conductscience.org/library/papers/42371546 | PubMed |
| 41730843 | Investigation of bile salt hydrolase activity in human gut bacteria reveals production of conjugated secondary bile acids. | Nat Commun | 2026 | https://conductscience.org/library/papers/41730843 | PubMed |
| 41582717 | Bile Acids as Key Mediators of the Gut Microbiota-Immune Axis: Potential Biomarker and Therapeutic Perspectives. | Biofactors | 2026 | https://conductscience.org/library/papers/41582717 | PubMed |
| 40814400 | Microbiota-derived bile acid metabolic enzymes and their impacts on host health. | Cell Insight | 2025 | https://conductscience.org/library/papers/40814400 | PubMed |
| 40093624 | Review on the Function, Substrate Affinity, and Potential Application of Bile Salt Hydrolase Originated from Probiotic Strains of Lactobacillus, Bifidobacterium, and Enterococcus. | Food Sci Anim Resour | 2025 | https://conductscience.org/library/papers/40093624 | PubMed |
| 40076032 | Multi-Omics Analysis Reveals the Negative Effects of High-Concentrate Diets on the Colonic Epithelium of Dumont Lambs. | Animals (Basel) | 2025 | https://conductscience.org/library/papers/40076032 | PubMed |
| 39936104 | Effect of SY009, a novel SGLT1 inhibitor, on the plasma metabolome and bile acids in patients with type 2 diabetes mellitus. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/39936104 | PubMed |
| 39569932 | B. vulgatus ameliorates high-fat diet-induced obesity through modulating intestinal serotonin synthesis and lipid absorption in mice. | Gut Microbes | 2024 | https://conductscience.org/library/papers/39569932 | PubMed |
| 38867937 | Taxonomic identification of bile salt hydrolase-encoding lactobacilli: Modulation of the enterohepatic bile acid profile. | Imeta | 2023 | https://conductscience.org/library/papers/38867937 | PubMed |
| 38312612 | Gut microbiota-derived metabolites associate with circulating immune cell subsets in unexplained recurrent spontaneous abortion. | Heliyon | 2024 | https://conductscience.org/library/papers/38312612 | PubMed |
| 37985845 | Using 16S rDNA and metagenomic sequencing technology to analyze the fecal microbiome of children with avoidant/restrictive food intake disorder. | Sci Rep | 2023 | https://conductscience.org/library/papers/37985845 | PubMed |
| 37111068 | Emerging Roles of Gut Microbial Modulation of Bile Acid Composition in the Etiology of Cardiovascular Diseases. | Nutrients | 2023 | https://conductscience.org/library/papers/37111068 | PubMed |
| 36894566 | Gut microbiota alters host bile acid metabolism to contribute to intrahepatic cholestasis of pregnancy. | Nat Commun | 2023 | https://conductscience.org/library/papers/36894566 | PubMed |
| 36544573 | Chemical proteomic analysis of bile acid-protein targets in Enterococcus faecium. | RSC Chem Biol | 2022 | https://conductscience.org/library/papers/36544573 | PubMed |
| 36363516 | Fecal Microbiota Transplantation in NAFLD Treatment. | Medicina (Kaunas) | 2022 | https://conductscience.org/library/papers/36363516 | PubMed |
| 36034447 | Gut microbiota: A new target for T2DM prevention and treatment. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36034447 | PubMed |
| 35954180 | Versatile Triad Alliance: Bile Acid, Taurine and Microbiota. | Cells | 2022 | https://conductscience.org/library/papers/35954180 | PubMed |
| 35888771 | Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota. | Metabolites | 2022 | https://conductscience.org/library/papers/35888771 | PubMed |
| 35807844 | Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis. | Nutrients | 2022 | https://conductscience.org/library/papers/35807844 | PubMed |
| 35429253 | The role of bile acids in carcinogenesis. | Cell Mol Life Sci | 2022 | https://conductscience.org/library/papers/35429253 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10993
GET https://conductscience.org/api/papers/v1/10993/cited_by?page=2